Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder

World Journal of Biological Psychiatry

Volumn 16, Issue 2, 2015, Pages 106-113

  Schmidt, Frank Martin ^a   Mergl, Roland ^a   Stach, Barbara ^a   Jahn, Ina ^a   Schönknecht, Peter ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Major depressive disorder; Neuron specific enolase; Neuronal biomarker; NSE; S100B

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DULOXETINE; LITHIUM; MIRTAZAPINE; NEURON SPECIFIC ENOLASE; OLANZAPINE; PROMETHAZINE; PROTEIN S100B; REBOXETINE; SERTRALINE; VALPROIC ACID; BIOLOGICAL MARKER; ENOLASE; S100B PROTEIN, HUMAN;

ADULT; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; EFFECT SIZE; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; ONSET AGE; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; CEREBROSPINAL FLUID; GLIA; PATHOLOGY; PUNCTURE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROGLIA; PHOSPHOPYRUVATE HYDRATASE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SPINAL PUNCTURE;

EID: 84923105498     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2014.952776     Document Type: Article

References (54)

1. Abumaria N, Rygula R, Hiemke C, Fuchs E, Havemann-Reinecke U, Rüther E, et al. 2007. Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat. Eur Neuropsychopharmacol 17:417-429.
2. Ahmad O, Wardlaw J, Whiteley WN. 2012. Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review. Cerebrovasc Dis 33:47-54.
3. Akhisaroglu M, Manev R, Akhisaroglu E, Uz T, Manev H. 2003. Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus. NeuroReport 14: 1471-1473.
4. Banerjee R, Ghosh AK, Ghosh B, Bhattacharyya S, Mondal AC. 2013. Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: An analysis in human postmortem brain. Clin Med Insights Pathol 6:1-11.
5. Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, et al. 2011. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68:1624-1630.
6. Casmiro M, Maitan S, de Pasquale F, Cova V, Scarpa E, Vignatelli L; NSE Study Group. 2005. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population. Eur J Neurol 12:369-374.
7. Cohen, J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
8. Cooper EH. 1999. Neuron-specific enolase. Int J Biol Markers 9:205-210.
9. Duan P, Zhang Y, Han X, Liu J, Yan W, Xing Y. 2012. Effect of neuronal induction on NSE, Tau, and Oct4 promoter methylation in bone marrow mesenchymal stem cells. In Vitro Cell Dev Biol Anim 48:251-258.
10. First MB, Spitzer RL, Gibbon M, Williams JBW. 1997. Structured Clinical Interview for DSM-IV Axis I disorders (SCID I). New York: Biometric Research Department.
11. Frodl T, Möller H-J, Meisenzahl E. 2008. Neuroimaging genetics: new perspectives in research on major depression? Acta Psychiatr Scand 118:363-372.
12. Fujiya A, Nagasaki H, Seino Y, Okawa T, Kato J, Fukami A, et al. 2014. The role of S100B in the interaction between adipocytes and macrophages. Obesity 22:371-379.
13. Gonc¸alves CA, Leite MC, Guerra MC. 2010. Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovasc Psychiatry Neurol 2010:790431.
14. Grabe HJ, Ahrens N, Rose HJ, Kessler C, Freyberger HJ. 2001. Neurotrophic factor S100 beta in major depression. Neuropsychobiology 44:88-90.
15. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
16. Hattori T, Takei N, Mizuno Y, Kato K, Kohsaka S. 1995. Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci Res 21:191-198.
17. Hein née Maier K, Köhler A, Diem R, Sättler MB, Demmer I, Lange P, et al. 2008. Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis. Neurosci Lett 436:72-76.
18. Jakobsson J, Bjerke M, Ekman CJ, Sellgren C, Johansson AG, Zetterberg H, et al. 2014. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of Bipolar Disorder patients. Neuropsychopharmacology 39:2349-2356.
19. Jang BS, Kim H, Lim SW, Jang KW, Kim DK. 2008. Serum S100B levels and major depressive disorder: Its characteristics and role in antidepressant response. Psychiatry Invest 5:193-198.
20. Kaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W. 1989. Clinical biochemistry of neuron specific enolase. Clin Chim Acta 183:13-31.
21. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al. 2003. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97:2806-2813.
22. Kern N, Sheldrick AJ, Schmidt FM, Minkwitz J. 2012. Neurobiology of depression and novel antidepressant drug targets. Curr Pharm Des 18:5791-5801.
23. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age of onset distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602.
24. Kuhn M, Popovic A, Pezawas L. 2014. Neuroplasticity and memory formation in major depressive disorder: An imaging genetics perspective on serotonin and BDNF. Restor Neurol Neurosci 32:25-49.
25. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H. 2013. Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry 25:592-603.
26. Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V Jr, da Silva Vargas R, et al. 2007. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421:33-36.
27. Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L, et al. 2012. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 20:644-659.
28. Nygaard O, Langbakk B, Romner B. 1998. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scand J Clin Lab Invest 58:183-186.
29. Parker TG, Marks A, Tsoporis JN. 1998. Induction of S100b in myocardium: an intrinsic inhibitor of cardiac hypertrophy. Can J Appl Physiol 23:377-389.
30. Pollak D, CairnS N, Lubec G. 2003. Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease. J Neural Transm (Suppl) 67:149-158.
31. Rajkowska G. 2000. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766-777.
32. Rajkowska G, Stockmeier CA. 2013. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets 14:1225-1236.
33. Rong H, Wang G, Liu T, Wang H, Wan Q, Weng S 2010. Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor. Int J Mol Sci 11:5310-5322.
34. Sacher J, Neumann J, Fünfstück T, Soliman A, Villringer A, Schroeter ML. 2012. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord 140:142-148.
35. Savitz JB, Rauch SL, Drevets WC. 2013. Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play. Mol Psychiatry 18:528-539.
36. Schindler S, Geyer S, Strauß M, Anwander A, Hegerl U, Turner R, et al. 2012. Structural studies of the hypothalamus and its nuclei in mood disorders. Psychiatry Res 201:1-9.
37. Schmidt FM, Lichtblau N, Minkwitz J, Chittka T, Thormann J, Kirkby KC, et al. 2014. Cytokine levels in depressed and nondepressed subjects, and masking effects of obesity. J Psychiatr Res 55:29-34.
38. Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. 2008. Serum markers support disease-specific glial pathology in major depression. J Affect Disord 111:271-280.
39. Schroeter ML, Steiner J, Mueller K. 2011. Glial pathology is modified by age in mood disorders - a systematic metaanalysis of serum S100B in vivo studies. J Affect Disord 134:32-38.
40. Sen J, Belli A. 2007. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res. 85:1373-1380.
41. Shapiro LA, Bialowas-McGoey LA, Whitaker-Azmitia PM. 2010. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in Down syndrome and Alzheimer's disease: Studies in an S100B overexpressing mouse model. Cardiovasc Psychiatry Neurol 2010:153657.
42. Song YJ, Korgaonkar MS, Armstrong LV, Eagles S, Williams LM, Grieve SM. 2014. Tractography of the brainstem in major depressive disorder using diffusion tensor imaging. PLoS One 9:e84825.
43. Steiner J, Bernstein HG, Bielau H, Berndt A, Brisch R, Mawrin C, et al. 2007. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 8:2.
44. Steiner J, Myint AM, Schiltz K, Westphal S, Bernstein HG, Walter M, et al. 2010. S100B Serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovasc Psychiatry Neurol 2010:480707.
45. Streitbürger DP, Arelin K, Kratzsch J, Thiery J, Steiner J, Villringer A, et al. 2012. Validating serum S100B and Neuron-Specific Enolase as biomarkers for the human brain-A combined serum, gene expression and MRI study. PLoS One 7:e43284.
46. Takei N, Kondo J, Nagaike K, Ohsawa K, Kato K, Kohsaka S. 1991. Neuronal survival factor from bovine brain is identical to neuron-specific enolase. J Neurochem 57:1178-11184.
47. Tramontina AC, Tramontina F, Bobermin LD, Zanotto C, Souza DF, Leite MC, et al. 2008. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 32 (6):1580-1583.
48. Uher T, Bob P. 2012. Cerebrospinal fluid S100B levels reflect symptoms of depression in patients with non-inflammatory neurological disorders. Neurosci Lett 529:139-143.
49. Wiener CD, Jansen K, Ghisleni G, Kaster MP, Souza LD, Lara DR, et al. 2013. Reduced serum levels of neuron specific enolase (NSE) in drug-na ï ve subjects with major depression and bipolar disorder. Neurochem Res 38:1394-1398.
50. World Health Organization (WHO) web site. Depression. http://www.who.int/mental_health/management/depression/en/ (accessed January 2014).
51. Wulsin LR, Vaillant GE, Wells VE. 1999. A systematic review of the mortality of depression. Psychosom Med 61:6-17.
52. Yang K, Xie GR, Hu YQ, Mao FQ, Su LY. 2008. The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression. J Neural Transm 115:1687-1694.
53. Youden WJ. 1950. Index for rating diagnostic tests. Cancer 3:32-35.
54. Yuan P, Zhou R, Wang Y, Li X, Li J, Chen G, Guitart X, Manji HK. 2010. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affect Disord 124:164-169.